0000899243-19-010426.txt : 20190409
0000899243-19-010426.hdr.sgml : 20190409
20190409212718
ACCESSION NUMBER: 0000899243-19-010426
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190325
FILED AS OF DATE: 20190409
DATE AS OF CHANGE: 20190409
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bratton Capital Inc.
CENTRAL INDEX KEY: 0001723783
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38311
FILM NUMBER: 19740449
BUSINESS ADDRESS:
STREET 1: 201 MAIN STREET
STREET 2: SUITE 1900
CITY: FORT WORTH
STATE: TX
ZIP: 76102
BUSINESS PHONE: 817.339.7600
MAIL ADDRESS:
STREET 1: 201 MAIN STREET
STREET 2: SUITE 1900
CITY: FORT WORTH
STATE: TX
ZIP: 76102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bratton Capital Management, L.P.
CENTRAL INDEX KEY: 0001723787
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38311
FILM NUMBER: 19740450
BUSINESS ADDRESS:
STREET 1: 201 MAIN STREET
STREET 2: SUITE 1900
CITY: FORT WORTH
STATE: TX
ZIP: 76102
BUSINESS PHONE: 817.339.7600
MAIL ADDRESS:
STREET 1: 201 MAIN STREET
STREET 2: SUITE 1900
CITY: FORT WORTH
STATE: TX
ZIP: 76102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Neuro Line Partners LP
CENTRAL INDEX KEY: 0001723842
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38311
FILM NUMBER: 19740451
BUSINESS ADDRESS:
STREET 1: 201 MAIN STREET
STREET 2: SUITE 1900
CITY: FORT WORTH
STATE: TX
ZIP: 76102
BUSINESS PHONE: 817.339.7600
MAIL ADDRESS:
STREET 1: 201 MAIN STREET
STREET 2: SUITE 1900
CITY: FORT WORTH
STATE: TX
ZIP: 76102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRATTON DOUGLAS K
CENTRAL INDEX KEY: 0001281933
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38311
FILM NUMBER: 19740452
MAIL ADDRESS:
STREET 1: 201 MAIN STREET
STREET 2: SUITE 1900
CITY: FORT WORTH
STATE: TX
ZIP: 76102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Denali Therapeutics Inc.
CENTRAL INDEX KEY: 0001714899
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463872213
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 866-8548
MAIL ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-25
0
0001714899
Denali Therapeutics Inc.
DNLI
0001281933
BRATTON DOUGLAS K
201 MAIN STREET, SUITE 1900
FORT WORTH
TX
76102
0
0
1
0
0001723842
Neuro Line Partners LP
201 MAIN STREET, SUITE 1900
FORT WORTH
TX
76102
0
0
1
0
0001723787
Bratton Capital Management, L.P.
201 MAIN STREET, SUITE 1900
FORT WORTH
TX
76102
0
0
1
0
0001723783
Bratton Capital Inc.
201 MAIN STREET, SUITE 1900
FORT WORTH
TX
76102
0
0
1
0
Common Stock
2019-03-25
4
J
0
158764
D
953035
I
By Neuro Line Partners, L.P.
Common Stock
19462499
I
By AKDL, L.P.
Pro rata in-kind distribution of shares of common stock, par value $0.01 per share, (the "Common Stock") of Denali Therapeutics Inc. from Neuro Line Partners, L.P. ("Neuro Line") to limited partners of Neuro Line without consideration.
The shares of Common Stock reported in Column 5 are held directly by Neuro Line. The general partner of Neuro Line is Bratton Capital Management, L.P. ("Bratton Capital Management"). The general partner of Bratton Capital Management is Bratton Capital, Inc. ("Bratton Capital"). Douglas K. Bratton is the sole director of Bratton Capital. Neuro Line is ultimately controlled by Mr. Bratton and Mr. Bratton has voting and investment power over all securities held by Neuro Line. In addition, Bratton Capital Management, Bratton Capital, and Mr. Bratton may be deemed to have a pecuniary interest in a portion of the securities held by Neuro Line due to Bratton Capital Management's right to receive performance-based allocations and Bratton Capital Management and Mr. Bratton may be deemed to have a pecuniary interest in a portion of the securities held by Neuro Line through direct or indirect limited partner and/or general partner interests in Neuro Line.
(Continued from Footnote 2) Bratton Capital Management, Bratton Capital and Mr. Bratton may each be deemed to beneficially own the securities held by Neuro Line. Each such entity and Mr. Bratton disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein.
These shares of Common Stock reported in Column 5 are held directly by AKDL, L.P. ("AKDL"). The general partner of AKDL is Crestline SI (GP), L.P. ("Crestline SI") and the investment manager of AKDL is Crestline Management, L.P. ("Crestline Management"). Crestline Investors, Inc. ("Crestline") is the general partner of both Crestline SI and Crestline Management. Douglas K. Bratton is the sole director of Crestline. AKDL is ultimately controlled by Mr. Bratton and Mr. Bratton has voting and investment power over all securities held by AKDL. In addition, Crestline SI, Crestline and Mr. Bratton may be deemed to have a pecuniary interest in a portion of the securities held by AKDL through direct or indirect limited partner interests, including limited partner profit interests, and/or general partner interests in AKDL.
(Continued from Footnote 4) Crestline SI, Crestline Management, Crestline and Mr. Bratton may each be deemed to beneficially own the securities held by AKDL. Each such entity and Mr. Bratton disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein.
DOUGLAS K. BRATTON, Name: /s/ Douglas K. Bratton
2019-04-09
NEURO LINE PARTNERS, L.P., By: Bratton Capital Management, L.P., its general partner, By: Bratton Capital, Inc., its general partner, Name: /s/ Douglas K. Bratton, Title: Sole Director
2019-04-09
BRATTON CAPITAL MANAGEMENT, L.P., By: Bratton Capital, Inc., its general partner, Name: /s/ Douglas K. Bratton, Title: Sole Director
2019-04-09
BRATTON CAPITAL, INC., Name: /s/ Douglas K. Bratton, Title: Sole Director
2019-04-09